2017
DOI: 10.1016/j.jconrel.2017.10.041
|View full text |Cite
|
Sign up to set email alerts
|

Doxorubicin-conjugated Escherichia coli Nissle 1917 swimmers to achieve tumor targeting and responsive drug release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
74
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 106 publications
(78 citation statements)
references
References 44 publications
2
74
0
Order By: Relevance
“…These results agree with other data reported by other research groups which indicate that the presence of Doxorubicin does not affect significantly neither growth nor viability of bacteria. [ 25 ]…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…These results agree with other data reported by other research groups which indicate that the presence of Doxorubicin does not affect significantly neither growth nor viability of bacteria. [ 25 ]…”
Section: Resultsmentioning
confidence: 99%
“…[ 22 ] Moreover, these tiny microorganisms are able to move toward gradients in response to small changes in internal stimulus (specific chemicals, temperature, or pH variations), or guided by external stimulus (magnetic field). [ 23–27 ] Thus, anaerobes bacteria are able to colonize hypoxic regions into tumoral tissues reaching inner zones of the malignancy, as has been studied in vitro and in vivo. [ 28–30 ] Herein, we report the use of Escherichia coli ( E. coli) as model of facultative anaerobic bacteria for the transportation of mesoporous silica nanoparticles (MSN) loaded with a potent cytotoxic compound, doxorubicin (Dox).…”
Section: Introductionmentioning
confidence: 99%
“…Another important aspect of biohybrids is their biological safety. For example, despite the claims of using bacterial biohybrid microswimmers for human health applications, such as drug delivery (reviewed in reference [30]), the references to the investigation of probiotic bacteria [31] or microorganisms with granted Qualified Presumption of Safety (QPS, from the European Food Safety Authority (EFSA)) [32] or Generally Recognized as Safe (GRAS, from the US Food and Drug Administration (FDA)) status as biohybrid carriers, are scarce [3,33,34]. Interestingly, most probiotic bacteria (e.g., Lactobacilli and Bifidobacteria) [31] and bacteria with QPS status [35] are Gram-positives.…”
Section: Figurementioning
confidence: 99%
“…Potential applications such as microsurgery [ 4 ], tumor imaging and ablation [ 5 , 6 ], tissue biopsies [ 7 ], targeted drug delivery [ 8 , 9 , 10 ], cell delivery [ 11 , 12 ], and gene silencing [ 13 , 14 ] have recently been explored, with demonstrations of microrobot viability in both in vitro and in vivo conditions. Polymer nanoplatforms have been shown to release chemicals to different stimuli such as presence of certain enzymes, pH changes, temperature differences, ultrasound, etc.…”
Section: Introductionmentioning
confidence: 99%